Hyunkyoung Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Reply to "Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time".

Reply to "Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time".

Journal: The journal of allergy and clinical immunology. In practice

Published: August 20, 2025

Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study.

Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study.

Journal: The journal of allergy and clinical immunology. In practice

Published: February 04, 2025

Impact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM Study.

Impact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM Study.

Journal: Allergy, asthma & immunology research

Published: January 08, 2025

Serum neuropilin-1 level may predict airway remodeling based on age and smoking status in asthma.

Serum neuropilin-1 level may predict airway remodeling based on age and smoking status in asthma.

Journal: Asia Pacific allergy

Published: October 16, 2024

Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthma.

Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthma.

Journal: ERJ open research

Published: September 25, 2024

Serum and urine eosinophil-derived neurotoxin (EDN) levels predict biologic response in severe asthma.

Serum and urine eosinophil-derived neurotoxin (EDN) levels predict biologic response in severe asthma.

Journal: The World Allergy Organization journal

Published: June 30, 2024

Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment.

Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment.

Journal: The World Allergy Organization journal

Published: June 05, 2024

Predictors of Early and Late Lung Function Improvement in Severe Eosinophilic Asthma on Type2-Biologics in the PRISM Study.

Predictors of Early and Late Lung Function Improvement in Severe Eosinophilic Asthma on Type2-Biologics in the PRISM Study.

Journal: Lung

Published: October 31, 2023

Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM study.

Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM study.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: September 04, 2023

A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study.

A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study.

Journal: The World Allergy Organization journal

Published: July 19, 2023

WITHDRAWN: Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.

WITHDRAWN: Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: February 28, 2023

Showing 1-11 of 11

Last Updated: 09/26/2026